Summary. Doripenem, a member of the β-lactam class of antibiotics, is the newest addition to the carbapenems. It exhibits concentration-independent bactericidal activity against gram-positive ...

New research has identified the genetic elements responsible for turning classical Klebsiella pneumoniae, which generally infects only sick and/or immunocompromised people in the health care setting, ...

Phare Bio has been awarded $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The biotech ...

A new report from the CDC published Thursday found antimicrobial-resistant bacterial infections are spreading in Ukraine amid ...

The emergence of resistant to carbapenems Gram-negative bacteria (CR GNB) has severely challenged antimicrobial therapy. Many CR GNB isolates are only susceptible to polymyxins; however ...

Among Gram-negative bacteria, which are some of the most resistant to antimicrobial drugs, resistance to carbapenems increased more than any other type of antibiotic, from 127,000 in 1990 to ...

Drugs called carbapenems are used when an infection cannot be treated with anything else. The spread of resistant Klebsiella pneumoniae was "extremely concerning", researchers from the Sanger ...

Among Gram-negative bacteria –some of the most resistant to antimicrobial drugs – resistance to carbapenems increased more than any other type of antibiotic, from 127,000 in 1990 to 216,000 in ...

Researchers have identified the genetic elements responsible for turning classical Klebsiella pneumoniae into hypervirulent ...

They include penicillin and its derivatives, such as methicillin and amoxicillin, as well as other groups of antibiotics known as the cephalosporins, carbapenems, and monobactams. The beta-lactam ring ...

A high rate of resistance was seen among UTI causing E. choli and Klebsiella pneumoniae and Acinetobacter baumannii against ...

UB research has identified the genetic elements responsible for turning classical Klebsiella pneumoniae, which generally infects only sick and/or immunocompromised people in the health care setting, ...